Showing results (21-30 of 352) with videos related to
Sort By:
Pageof 36
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Toward Better Data Dashboards for US Drug Value AssessmentsPeter J NeumannHealth Affairs (Project Hope)|March 9, 2004
Evidence-based and value-based formulary guidelinesPeter J NeumannPharmacoeconomics|June 18, 2005
Health utilities in Alzheimer's disease and implications for cost-effectiveness analysisPeter J NeumannHealth Affairs (Project Hope)|June 8, 2006
Emerging lessons from the drug effectiveness review projectPeter J NeumannThe American Journal of Managed Care|May 22, 2004
Why don't Americans use cost-effectiveness analysis?Peter J NeumannMedical Care|June 19, 2009
Costing and perspective in published cost-effectiveness analysisPeter J NeumannHealth Affairs (Project Hope)|January 30, 2007
Challenges ahead for federal technology assessmentPeter J NeumannMedical Care|August 2, 2005
The arrival of economic evidence in managed care formulary decisions: the unsolicited request processPeter J NeumannPageof 36